These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7872321

  • 1. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.
    Wingard RL, Parker RA, Ismail N, Hakim RM.
    Am J Kidney Dis; 1995 Mar; 25(3):433-9. PubMed ID: 7872321
    [Abstract] [Full Text] [Related]

  • 2. A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGEN.
    Johnson CA, Rosowski E, Zimmerman SW.
    Adv Perit Dial; 1992 Mar; 8():444-7. PubMed ID: 1361844
    [Abstract] [Full Text] [Related]

  • 3. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M, Uday K, Henriquez M, Blum S, Dave M.
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract] [Full Text] [Related]

  • 4. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin.
    Markowitz GS, Kahn GA, Feingold RE, Coco M, Lynn RI.
    Clin Nephrol; 1997 Jul; 48(1):34-40. PubMed ID: 9247776
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C, Boquinhas H, Gaspar A, Adragão T, Boquinhas JM, Júnior EC, Simões J.
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients.
    Greenbaum LA, Pan CG, Caley C, Nelson T, Sheth KJ.
    Pediatr Nephrol; 2000 Sep; 14(10-11):908-11. PubMed ID: 10975297
    [Abstract] [Full Text] [Related]

  • 12. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Fishbane S, Frei GL, Maesaka J.
    Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266
    [Abstract] [Full Text] [Related]

  • 13. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ.
    Am J Nephrol; 2000 Jul; 20(6):455-62. PubMed ID: 11146312
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
    Fishbane S, Lynn RI.
    Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
    Ahluwalia N, Skikne BS, Savin V, Chonko A.
    Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
    [Abstract] [Full Text] [Related]

  • 17. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Dec; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.